Selected research
Industry Research
Prescription Arthritis Medications Industry Research Report 2026
Market perspective
The global Prescription Arthritis Medications market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Prescription Arthritis Medications is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Prescription Arthritis Medications is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Prescription Arthritis Medications is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Prescription Arthritis Medications include Boehringer Ingelheim, Horizon Pharma, Amgen, Pfizer, Novartis, Abbott and Regeneron, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Prescription Arthritis Medications market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Prescription Arthritis Medications Market by Company
Boehringer Ingelheim
Horizon Pharma
Amgen
Pfizer
Novartis
Abbott
Regeneron
Prescription Arthritis Medications Segment by Type
Oral
Topical
Prescription Arthritis Medications Segment by Application
Online Pharmacies
Hospital Pharmacies
Retail Pharmacies
Prescription Arthritis Medications Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Arthritis Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prescription Arthritis Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Arthritis Medications.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Prescription Arthritis Medications manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Prescription Arthritis Medications by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Prescription Arthritis Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Topical
Applications
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
Companies covered
- Boehringer Ingelheim
- Horizon Pharma
- Amgen
- Pfizer
- Novartis
- Abbott
- Regeneron
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Prescription Arthritis Medications Market Size (2021-2032)
- 2.2.2 Global Prescription Arthritis Medications Sales (2021-2032)
- 2.2.3 Global Prescription Arthritis Medications Market Average Price (2021-2032)
- 2.3 Prescription Arthritis Medications by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral
- 2.3.3 Topical
- 2.4 Prescription Arthritis Medications by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Pharmacies
- 2.4.3 Hospital Pharmacies
- 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Prescription Arthritis Medications Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Prescription Arthritis Medications Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Prescription Arthritis Medications Revenue of Manufacturers (2021-2026)
- 3.4 Global Prescription Arthritis Medications Average Price by Manufacturers (2021-2026)
- 3.5 Global Prescription Arthritis Medications Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Prescription Arthritis Medications, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Prescription Arthritis Medications, Product Type & Application
- 3.8 Global Manufacturers of Prescription Arthritis Medications, Established Date
- 3.9 Global Prescription Arthritis Medications Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Boehringer Ingelheim
- 4.1.1 Boehringer Ingelheim Company Information
- 4.1.2 Boehringer Ingelheim Business Overview
- 4.1.3 Boehringer Ingelheim Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Boehringer Ingelheim Prescription Arthritis Medications Product Portfolio
- 4.1.5 Boehringer Ingelheim Recent Developments
- 4.2 Horizon Pharma
- 4.2.1 Horizon Pharma Company Information
- 4.2.2 Horizon Pharma Business Overview
- 4.2.3 Horizon Pharma Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Horizon Pharma Prescription Arthritis Medications Product Portfolio
- 4.2.5 Horizon Pharma Recent Developments
- 4.3 Amgen
- 4.3.1 Amgen Company Information
- 4.3.2 Amgen Business Overview
- 4.3.3 Amgen Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Amgen Prescription Arthritis Medications Product Portfolio
- 4.3.5 Amgen Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Prescription Arthritis Medications Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Novartis
- 4.5.1 Novartis Company Information
- 4.5.2 Novartis Business Overview
- 4.5.3 Novartis Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novartis Prescription Arthritis Medications Product Portfolio
- 4.5.5 Novartis Recent Developments
- 4.6 Abbott
- 4.6.1 Abbott Company Information
- 4.6.2 Abbott Business Overview
- 4.6.3 Abbott Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Abbott Prescription Arthritis Medications Product Portfolio
- 4.6.5 Abbott Recent Developments
- 4.7 Regeneron
- 4.7.1 Regeneron Company Information
- 4.7.2 Regeneron Business Overview
- 4.7.3 Regeneron Prescription Arthritis Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Regeneron Prescription Arthritis Medications Product Portfolio
- 4.7.5 Regeneron Recent Developments
5 Global Prescription Arthritis Medications Market Scenario by Region
- 5.1 Global Prescription Arthritis Medications Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Prescription Arthritis Medications Sales by Region: 2021-2032
- 5.2.1 Global Prescription Arthritis Medications Sales by Region: 2021-2026
- 5.2.2 Global Prescription Arthritis Medications Sales by Region: 2027-2032
- 5.3 Global Prescription Arthritis Medications Revenue by Region: 2021-2032
- 5.3.1 Global Prescription Arthritis Medications Revenue by Region: 2021-2026
- 5.3.2 Global Prescription Arthritis Medications Revenue by Region: 2027-2032
- 5.4 North America Prescription Arthritis Medications Market Facts & Figures by Country
- 5.4.1 North America Prescription Arthritis Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Prescription Arthritis Medications Sales by Country (2021-2032)
- 5.4.3 North America Prescription Arthritis Medications Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Prescription Arthritis Medications Market Facts & Figures by Country
- 5.5.1 Europe Prescription Arthritis Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Prescription Arthritis Medications Sales by Country (2021-2032)
- 5.5.3 Europe Prescription Arthritis Medications Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Prescription Arthritis Medications Market Facts & Figures by Country
- 5.6.1 Asia Pacific Prescription Arthritis Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Prescription Arthritis Medications Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Prescription Arthritis Medications Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Prescription Arthritis Medications Market Facts & Figures by Country
- 5.7.1 South America Prescription Arthritis Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Prescription Arthritis Medications Sales by Country (2021-2032)
- 5.7.3 South America Prescription Arthritis Medications Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Prescription Arthritis Medications Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Prescription Arthritis Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Prescription Arthritis Medications Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Prescription Arthritis Medications Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Prescription Arthritis Medications Sales by Type (2021-2032)
- 6.1.1 Global Prescription Arthritis Medications Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Prescription Arthritis Medications Sales Market Share by Type (2021-2032)
- 6.2 Global Prescription Arthritis Medications Revenue by Type (2021-2032)
- 6.2.1 Global Prescription Arthritis Medications Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Prescription Arthritis Medications Revenue Market Share by Type (2021-2032)
- 6.3 Global Prescription Arthritis Medications Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Prescription Arthritis Medications Sales by Application (2021-2032)
- 7.1.1 Global Prescription Arthritis Medications Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Prescription Arthritis Medications Sales Market Share by Application (2021-2032)
- 7.2 Global Prescription Arthritis Medications Revenue by Application (2021-2032)
- 7.2.1 Global Prescription Arthritis Medications Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Prescription Arthritis Medications Revenue Market Share by Application (2021-2032)
- 7.3 Global Prescription Arthritis Medications Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Prescription Arthritis Medications Value Chain Analysis
- 8.1.1 Prescription Arthritis Medications Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Prescription Arthritis Medications Production Mode & Process
- 8.2 Prescription Arthritis Medications Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Prescription Arthritis Medications Distributors
- 8.2.3 Prescription Arthritis Medications Customers
9 Global Prescription Arthritis Medications Analyzing Market Dynamics
- 9.1 Prescription Arthritis Medications Industry Trends
- 9.2 Prescription Arthritis Medications Industry Drivers
- 9.3 Prescription Arthritis Medications Industry Opportunities and Challenges
- 9.4 Prescription Arthritis Medications Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst